Directory Last Updated: 28 March 2024
Return to Directory Special Interests word selected:- PHASE
* Information available to verified or subscribed users. The first stage in this process is to Register - please click here to Register.
If you have already Registered, please click here to login.
PhraseConsultantTownSpecial Interests
clinical research in clinical trials - phase 1
*Consultant(s)*
*Towns*Medical oncology, melanoma, clinical research in clinical trials - phase 1, urological oncology
core and swallowing outcomes in late phase clinical trials involving patients with OPSCC - oropharyngeal squamous cell carcinoma
*Consultant(s)*
*Towns*Early phase clinical trials, the role of the p53/MDM2 pathway in radioresistance and cellular motility, the therapeutic exploitation of the unfolded protein response in head and neck cancer, treatment response in HPV - human papilloma virus +ve oropharyngeal cancer intraoperative radiotherapy, core and swallowing outcomes in late phase clinical trials involving patients with OPSCC - oropharyngeal squamous cell carcinoma, function sparing surgical strategies for head and neck cancer - especially transoral laser microsurgery
development of early phase clinical trials of anti-cancer therapies
*Consultant(s)*
*Towns*Medical oncology, development of early phase clinical trials of anti-cancer therapies
early phase clinical trials
*Consultant(s)*
*Towns*Medical oncology, pancreatic cancer, gastrointestinal cancer, neuroendocrine tumours, early phase clinical trials
early phase clinical trials
*Consultant(s)*
*Towns*Paediatric neuro-oncology, neuroblastoma, early phase clinical trials
early phase clinical trials
*Consultant(s)*
*Towns*Medical oncology, gastrointestinal cancer, endocrine cancer, hepatobiliary tumours, early phase clinical trials
Early phase clinical trials
*Consultant(s)*
*Towns*Early phase clinical trials, the role of the p53/MDM2 pathway in radioresistance and cellular motility, the therapeutic exploitation of the unfolded protein response in head and neck cancer, treatment response in HPV - human papilloma virus +ve oropharyngeal cancer intraoperative radiotherapy, core and swallowing outcomes in late phase clinical trials involving patients with OPSCC - oropharyngeal squamous cell carcinoma, function sparing surgical strategies for head and neck cancer - especially transoral laser microsurgery
early phase clinical trials
*Consultant(s)*
*Towns*Medical oncology, drug development, ovarian cancer, endometrial cancer, cervical cancer, early phase clinical trials
early phase clinical trials
*Consultant(s)*
*Towns*Medical oncology, lung cancer, head and neck cancer, early phase clinical trials, immunotherapy
early phase clinical trials
*Consultant(s)*
*Towns*Medical oncology, metastatic melanoma, early phase clinical trials
early phase trials
*Consultant(s)*
*Towns*Medical oncology, thoracic oncology, lung cancer, early phase trials
early phase trials for childhood leukaemia
*Consultant(s)*
*Towns*Paediatric oncology, childhood leukaemia and lymphoma, early phase trials for childhood leukaemia
Lead Undergraduate Medical Students Phase 3a Obstetrics and Gynaecology
*Consultant(s)*
*Towns*Fertility, recurrent miscarriage, polycystic ovary syndrome - PCOS, Lead Undergraduate Medical Students Phase 3a Obstetrics and Gynaecology
phase 1 - 2 trials
*Consultant(s)*
*Towns*Medical oncology, breast cancer, cancer drug development, phase 1 - 2 trials
phase 1 drug development
*Consultant(s)*
*Towns*Medical oncology, lung cancer, head and neck cancer, phase 1 drug development
phase 1 trials
*Consultant(s)*
*Towns*Medical oncology, melanoma, liver cancer, inoperable cancer, phase 1 trials, upper gastrointestinal cancers
Spacer

Third Party Advertisement

Adverts by Google